William C. Gerth - Concepedia

Author

William C. Gerth

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

William C Gerth, William C. Gerth, William Gerth

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Brigham and Women's Hospital University of Michigan United States Military Academy University of Florida

About

William C. Gerth is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, public health, and health services research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.1K
2	Public Health	3	3	927
3	Business	1	1	21
4	Health Sciences	1	1	21
5	Nursing	1	1	796

William C. Gerth

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? Hans‐Georg Eichler, Sheldon X. Kong, William C. Gerth, Value in Health NursingPrimary CareCost-effectiveness AnalysisHealthcare ValueHealth Economics	2004	796
Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes Paul R. Conlin, William C. Gerth, James M. Fox, Clinical Therapeutics Non-pharmacological InterventionHypertensionCardiovascular DiseaseAntihypertensive TherapyPharmacology	2001	184
Antihypertensive persistence and drug class. Michael Marentette, William C. Gerth, David K. Billings, PubMed	2002	127
The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss William C. Gerth, George W. Carides, Erik J. Dasbach, PharmacoEconomics Migraine SymptomsHealth PolicyMultinational ImpactGlobal HealthInternational Health	2001	101
Costs and effects of enalapril therapy in patients with symptomatic heart failure: An economic analysis of the studies of left ventricular dysfunction (SOLVD) treatment trial Henry A. Glick, J.R. Cook, Bruce Kinosian, Journal of Cardiac Failure Heart FailureCardiovascular DiseaseLeft Ventricular DysfunctionCardiovascular PharmacologyDiastolic Function	1995	94
Losartan Reduces the Costs Associated With Diabetic End-Stage Renal Disease William H. Herman, Shahnaz Shahinfar, George W. Carides, Diabetes Care	2003	72
Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions Donghui Yu, Josh F. Peterson, Diane L. Seger, Pharmacoepidemiology and Drug Safety	2005	64
Burden of hospitalization of patients with Candida and Aspergillus infections in Australia Monica A. Slavin, John Fastenau, Isaya Sukarom, International Journal of Infectious Diseases	2003	61
Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever John R. Wingard, Helen Leather, Craig A. Wood, American Journal of Health-System Pharmacy	2007	33
Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada William C. Gerth, Stephen Betschel, Arthur S. Zbrozek Allergy Asthma and Clinical Immunology	2014	32

Page 1